Clinical trial
Prognostic Model of HCV-related Disease Progression After DAAs
NCT04631640 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Model of HCV-related Disease Progression After DAAs
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 1, 2020
- Completion date
- December 31, 2024
- Enrollment
- 234 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hcv